Introduction {#sec1_1}
============

Peritonitis is a serious and common complication of peritoneal dialysis (PD). Although only 5% of peritonitis episodes result in death, peritonitis is the direct or major contributing cause of death in around 16% of PD patients. Severe or prolonged peritonitis can also lead to structural and functional alterations of the peritoneal membrane, eventually leading to membrane failure which subsequently leads to transition to hemodialysis. This case confirms the need for prophylactic antibiotics prior to invasive gastrointestinal procedures to prevent peritonitis.

Case Report {#sec1_2}
===========

A 57-year-old female with rectal cancer successfully treated with chemotherapy and radiation over a year ago, renal cell cancer with subsequent nephrectomy and ESRD from lupus nephritis, and on PD since 2014 presented to an outside hospital with melena. She underwent colonoscopy and endoscopy that revealed a clean-based duodenal ulcer that was treated with twice daily intravenous pantoprazole. Several days later, she presented with another gastrointestinal bleed requiring repeat upper endoscopy and subsequently angiogram and coil embolization of the gastroduodenal artery. PD treatments were withheld and she received hemodialysis treatments via her arteriovenous fistula during this hospitalization. She had not received prophylactic antibiotics to prevent peritonitis prior to these procedures. In the interim, she was diagnosed with *Clostridium difficile* diarrhea, which was treated with oral vancomycin.

Following her second endoscopy, she developed diffuse abdominal pain and became febrile to 100.6°F. Her abdomen was soft but diffusely tender. Peritonitis was suspected and her peritoneal fluid effluent was drawn for analysis (Table [1](#T1){ref-type="table"}). Gram stain of the peritoneal fluid revealed gram-positive cocci, and cultures grew gram-positive micrococcus and *Candida tropicalis*. Intravenous vancomycin and oral fluconazole were initiated. Final culture growth revealed the CDC group EO-4 organism, which was susceptible to levofloxacin. She was switched to levofloxacin to complete a total of 2 weeks of antibiotics. She was discharged home on PD and was readmitted 1 day later for hematochezia. She continued to have abdominal cramps unchanged in severity from before, but bleeding scan followed by a third endoscopy remained negative.

She was then transferred to our institution for further evaluation and consideration for double-balloon enteroscopy. Upon arrival, her vital signs were stable: blood pressure 122/75 mm Hg, heart rate 85, temperature 97.6°F. Cardiac examination was benign and lungs were clear to auscultation. Her abdominal examination revealed an intact PD catheter exit site without erythema or exudate, a diffusely tender abdomen without rebound or guarding, no lower extremity edema, and the left upper extremity revealed a brachiocephalic arteriovenous fistula with bruit. Laboratory values were as follows: hemoglobin 10.8 g/dL, white blood cell count 4.2 × 10^9^/L, platelet count 110 × 10^9^/L, normal transaminases, alkaline phosphatase 245 IU/L, total bilirubin 0.3 mg/dL, serum albumin 1.3 g/dL, and serum lactate level 0.8 mmol/L. Serum coagulation studies were normal. Serum electrolytes revealed a bicarbonate level of 25 mmol/L, potassium 3.4 mmol/L, BUN 15 mg/dL, and creatinine 6.9 mg/dL. Urinalysis was benign with only 4 white cells/HPF and negative leukocyte esterase and nitrite. *Clostridium difficile* toxin was negative. Serum lipase was normal at 6 U/L. Peritoneal fluid cell count and culture was repeated at our institution (Table [1](#T1){ref-type="table"}). Abdominal CT with oral and intravenous contrast revealed wall thickening in the right colon extending to the proximal portion of the transverse colon compatible with regional colitis. There was a moderate amount of ascites related to PD. The PD catheter entered the right lower quadrant and coiled in the right lower quadrant. There was an abdominal wall fluid collection around the insertion of the PD catheter. Capsule endoscopy was unrevealing.

Given multiple gastrointestinal procedures, recent *C. difficile* infection which had been adequately treated, and incomplete treatment for a recent fungal peritonitis, her persistent abdominal pain was attributed to intractable catheter-related fungal peritonitis. Surgical catheter removal was performed and she was switched to hemodialysis. Catheter tip culture grew *C. tropicalis*. The fungal peritonitis was treated with oral fluconazole for 2 months. Her abdominal pain improved and she was discharged home.

Discussion {#sec1_3}
==========

In PD patients, peritonitis is diagnosed by abdominal pain, a cloudy dialysate effluent, and a peritoneal fluid white blood cell count greater than 100/µL and/or at least 50% neutrophils \[[@B1]\]. Peritonitis may arise from transmural migration of bacteria from the bowel to the peritoneal cavity after manipulation of the gastrointestinal tract \[[@B2]\]. Several reports have described the development of peritonitis in PD patients who underwent GI endoscopy without prophylaxis \[[@B3], [@B4], [@B5], [@B6]\], and a retrospective study found that the risk of peritonitis after colonoscopy without antibiotic prophylaxis was 6.3% \[[@B7]\]. Peritoneal fluid in these patients has yielded gram-positive and gram-negative organisms \[[@B2], [@B8]\]. The CDC group EO-3 organism has been reported to cause peritonitis in a PD patient \[[@B9]\]. However, this is the first report of a CDC group EO-4 organism causing peritonitis. It is an aerobic gram-negative organism which has been isolated from blood, urine, and nasal secretions \[[@B10]\].

Our patient developed fungal peritonitis, which is an indication for transition from PD to hemodialysis for at least 6 months. To reduce the risk of peritonitis in PD patients, the International Society of Peritoneal Dialysis recommends intravenous 1 g ampicillin plus one dose of aminoglycoside with or without metronidazole and emptying the abdomen of fluid before endoscopic procedures \[[@B11]\]. The American Society of Gastrointestinal Endoscopy suggests prophylactic antibiotics before colonoscopy \[[@B12]\]. Gastroenterologists, infectious disease specialists and nephrologists need to be aware of the risks of gastrointestinal procedures in PD patients without administering antibiotic prophylaxis.

Conclusion {#sec1_4}
==========

Gastrointestinal procedures without antibiotic prophylaxis in PD patients can lead to peritonitis, which leads to significant morbidity. Further randomized multicenter studies are needed in PD patients to determine prophylactic antibiotic class and efficacy.
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###### 

Peritoneal fluid analysis

  Days since admission   Fluid appearance   Fluid red cell count   Fluid white cell count   Fluid neutrophils   Organism
  ---------------------- ------------------ ---------------------- ------------------------ ------------------- ----------------------------------------------------------
  7                      Cloudy             \<3,000                97                       95%                 Gram-positive micrococcus, C. tropicalis, CDC group EO-4
  20                     Clear              0                      67                       75%                 *C. tropicalis*

[^1]: The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the US government.
